TLR Signalling and the Function of Dendritic Cells
Overview
Authors
Affiliations
The recognition of microbes by innate immune cells initiates activation of the whole immune system. Toll-like receptors (TLRs) are known to recognize various components of invading pathogens. At present, the natural ligands for almost all TLR members have been identified. TLRs are expressed on many types of cells including macrophages and dendritic cells (DCs). The recognition of invading microbes by TLRs on DCs induces proinflammatory cytokine production and enhanced antigen presentation to naive T cells, and finally activates antigen-specific adaptive immune responses. The sequential activation of innate and subsequent adaptive immunity are crucial steps to eradicate invading pathogens. Recently, the TLR signalling pathway has been intensively investigated. Accumulating evidence indicates that, at least, four adaptor molecules are involved in TLR signalling and provide their signalling specificities. Distinct TLR ligands provide distinct activation status and cytokine production patterns for antigen presenting cells, resulting in the induction of differential immune responses. Thus, TLRs are critical molecules to induce not only inflammatory responses but also fine-tuned adaptive immune responses depending on invading pathogens.
Long noncoding RNA PARAL1 regulates myeloid dendritic cell differentiation and TLR signaling.
Naqvi R, Valverde A, Shukla D, Naqvi A Genes Immun. 2025; .
PMID: 40000873 DOI: 10.1038/s41435-025-00323-9.
Anti-inflammatory Effects of the Fucoidan from Sea Cucumber Apostichopus japonicus.
Hou T, Liu X, Zhang S, Tang K, Liu S, Liu J Mar Biotechnol (NY). 2025; 27(1):32.
PMID: 39832054 DOI: 10.1007/s10126-025-10410-7.
Pan H, Liu C, Zhu H, Zhang G J Headache Pain. 2024; 25(1):196.
PMID: 39528917 PMC: 11555962. DOI: 10.1186/s10194-024-01906-z.
The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity.
Nguyen N, Muller R, Briukhovetska D, Weber J, Feucht J, Kunkele A Cancers (Basel). 2024; 16(14).
PMID: 39061247 PMC: 11274444. DOI: 10.3390/cancers16142608.
Kalkusova K, Taborska P, Stakheev D, Rataj M, Smite S, Darras E J Immunol Res. 2024; 2024:5537948.
PMID: 39056014 PMC: 11272405. DOI: 10.1155/2024/5537948.